Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe

Drug Testing and Analysis

Volumn 9, Issue 2, 2017, Pages 199-207

  Liu, Cuimei ^a   Jia, Wei ^b   Qian, Zhenhua ^b   Li, Tao ^b   Hua, Zhendong ^b  

^a INSTITUTE OF FORENSIC SCIENCE   (China)

^b NONE

Author keywords

5 AEDB; 5 APB NBOMe; 5 MAPDB; 6 Br MDMA; MDMA methylene homolog; new psychoactive substance; substituted phenethylamine derivatives

Indexed keywords

COPYRIGHTS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

5-AEDB; 5-APB-NBOME; 5-MAPDB; 6-BR-MDMA; ANALYTICAL PROPERTIES; DIHYDROBENZOFURANS; MDMA METHYLENE HOMOLOGUE; NEW PSYCHOACTIVE SUBSTANCE; PHENETHYLAMINES; SUBSTITUTED PHENETHYLAMINE DERIVATIVE;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

1 (BENZOFURAN 5 YL) N (2 METHOXYBENZYL)PROPAN 2 AMINE; 5 (2 AMINOETHYL) 2,3 DIHYDROBENZOFURAN; 5 (2 METHYLAMINOPROPYL) 2,3 DIHYDROBENZOFURAN; 6 BROMO 3,4 METHYLENEDIOXYMETHAMPHETAMINE; N,2 DIMETHYL 3 (3,4 METHYLENEDIOXYPHENYL)PROPAN 1 AMINE; PHENETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG; DESIGNER DRUG; MIDOMAFETAMINE; PHENETHYLAMINE; PSYCHOTROPIC AGENT;

ARTICLE; DRUG IDENTIFICATION; DRUG STRUCTURE; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; MASS SPECTROMETRY;

DESIGNER DRUGS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHENETHYLAMINES; PSYCHOTROPIC DRUGS;

EID: 84958794315     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1955     Document Type: Article

References (27)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). New psychoactive substances in Europe. An update from the EU Early Warning System. Lisbon. 2015. Available at: http://www.emcdda.europa.eu/publications/2015/new-psychoactive-substances [May 2015].
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report 2014: trends and developments. Lisbon. 2014. Available at: http://www.emcdda.europa.eu/attachements.cfm/att_228272_EN_TDAT14001ENN.pdf [May 2014].
3. Synthetics Monitoring: Analyses, Reporting and Trends (SMART). Global SMART update: legal responses to NPS: multiple approaches to a multi-faceted problem. 2015. Available at: http://www.unodc.org/documents/scientific/Global_SMART_Update_14-web.pdf [September 2015].
4. United Nations Office on Drugs and Crime (UNODC).The challenge of new psychoactive substances. 2013. Available at: www.unodc.org/documents/scientific/NPS_2013_SMART.pdf [March 2013].
5. B. V. Dean, S. J. Stellpflug, A. M. Burnett, K. M. Engebretsen. 2C or not 2C: Phenethylamine designer drug review. J. Med.Toxicol. 2013, 9, 172.
6. J. Welter-Luedeke, H. H. Maurer. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives with Modified Ring Systems. Ther. Drug Monit. 2015. DOI:10.1097/FTD.0000000000000240.
7. A. Rickli, S. Kopf, M. C. Hoener, M. E. Liechti. Pharmacological profile of novel psychoactive benzofurans. Brit. J. Pharmacol. 2015, 172, 3412.
8. A. P. Monte, D. Marona-Lewicka, N. V. Cozzi, D. E. Nichols. Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methy1enedioxy)amphetamine. J. Med. Chem. 1993, 36, 3700.
9. A. Shulgin, A. Shulgin. PIHKAL: A Chemical Love Story, Transform Press, Berkeley, CA 1991.
10. D. Zuba. Identification of cathinones and other active components of ‘legal highs' by mass spectrometric methods. Trends Anal. Chem. 2012, 32, 15.
11. J. F. Casale, P. A. Hays. The Characterization of 6-(2-aminopropyl)benzofuran and differentiation from its 4-, 5-, and 7-positional analogues. Microgram J. 2012, 9, 61.
12. A. Stanczuk, N. Morris, E. A. Gardner, P. Kavanagh. Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in Internet purchased products. Drug Test. Anal. 2013, 5, 270.
13. N. Uchiyama, Y. Shimokawa, M. Kawamura, R. Kikura-Hanajiri, T. Hakamatsuka. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol. 2014, 32, 266.
14. J. F. Casale, P. A. Hays. The characterization of 5- and 6-(2-aminopropyl)-2,3-dihydrobenzofuran. Microgram J. 2011, 8, 62.
15. n techniques. Anal. Bioanal. Chem. 2015, 407, 1371.
16. J. F. Casale, P. A. Hays. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues - Part I. Microgram J. 2012, 9, 84.
17. P. A. Hays, J. F. Casale. Characterization of eleven 2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (NBOMe) derivatives and differentiation from their 3- and 4-methoxybenzyl analogues - Part II. Microgram J. 2014, 11, 3.
18. D. Zuba, K. Sekuła. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs. Drug Test. Anal. 2013, 5, 634.
19. K. Sekuła, D. Zuba. Structural elucidation and identification of a new derivative of phenethylamine using quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2013, 27, 2081.
20. D. Zuba, K. Sekuła, A. Buczek. 25C-NBOMe –New potent hallucinogenic substance identified on the drug market. Forensic Sci. Int. 2013, 227, 7.
21. L. Bonde-Larsen, R. Lopez, F. Sainz, G. Fuentes. Method for obtaining 1,3-difunctionalized pyrrolldine derivatives. Ragactives, S.L., ES. European Patent No. 2010-EP 2236509 A1, 2010.
22. T. Matsumoto, R. Kikura-Hanajiri, H. Kamakura, N. Kawahara, Y. Goda. Identification of N-methyl-4-(3,4-methylenedioxyphenyl) butan-2-amine, distributed as MBDB. J. Health Sci. 2006, 52, 805.
23. N. Kato, S. Fujita, H. Ohta, M. Fukuba, A. Toriba, K. Hayakawa. Thin layer chromatography/ fluorescence detection of 3,4-methylenedioxy- methamphetamine and related compounds. J. Forensic Sci. 2008, 53, 1367.
24. A. T. Shulgin, P. Jacob. Potential misrepresentation of 3,4-methylene-dioxyamphetamine (MDA). A toxicological warning. J. Anal. Toxicol. 1982, 6, 71.
25. 3H-5-hydroxytryptamine. Pharmacol. Biochem. Behav. 1991, 38, 505.
26. F. Westphal, U. Girreser, D. Waldmüller. Analytical characterization of four new ortho-methoxybenzylated amphetamine-type designer drugs. Drug Test. Anal. 2015. DOI:10.1002/dta.1889.
27. R. J. Lewis, D. Reed, A. G. Service, A. M. Langford. The identification of 2-chloro-4,5 methylenedioxymethylamphetamine in an illicit drug seizure. J. Forensic Sci. 2000, 45, 1119.